129 related articles for article (PubMed ID: 7524234)
1. Morphometry of the prostate: I. Distribution of tissue components in hyperplastic glands.
Marks LS; Treiger B; Dorey FJ; Fu YS; deKernion JB
Urology; 1994 Oct; 44(4):486-92. PubMed ID: 7524234
[TBL] [Abstract][Full Text] [Related]
2. Is one single prostate biopsy helpful for choosing a medical treatment of benign prostatic hyperplasia? A quantitative computerized morphometric study.
Zlota Ar; Sattar AA; Wespes E; Noel JC; Schulman CC
Urology; 1996 Mar; 47(3):329-34. PubMed ID: 8633397
[TBL] [Abstract][Full Text] [Related]
3. The relative proportion of stromal and epithelial hyperplasia is related to the development of symptomatic benign prostate hyperplasia.
Shapiro E; Becich MJ; Hartanto V; Lepor H
J Urol; 1992 May; 147(5):1293-7. PubMed ID: 1373778
[TBL] [Abstract][Full Text] [Related]
4. Relationship between the prostatic tissue components and natural history of benign prostatic hyperplasia.
Matsuda T; Fujime M; Suda K
Anal Quant Cytol Histol; 2006 Jun; 28(3):121-4. PubMed ID: 16786720
[TBL] [Abstract][Full Text] [Related]
5. Percentage area density of epithelial and mesenchymal components in benign prostatic hyperplasia: comparison of results between single biopsy, multiple biopsies and multiple tissue specimens.
Robert M; Costa P; Bressolle F; Mottet N; Navratil H
Br J Urol; 1995 Mar; 75(3):317-24. PubMed ID: 7537601
[TBL] [Abstract][Full Text] [Related]
6. Morphometric quantitation of stroma in human benign prostatic hyperplasia.
Deering RE; Bigler SA; King J; Choongkittaworn M; Aramburu E; Brawer MK
Urology; 1994 Jul; 44(1):64-70. PubMed ID: 7518983
[TBL] [Abstract][Full Text] [Related]
7. [Quantitative morphometry of hyperplastic hypoechoic nodules in the prostatic outer gland].
Li X; Wang N; Shi HY; Zhang Y; Fu XS; Li JL; Xu JH; Tang J
Zhonghua Nan Ke Xue; 2005 Feb; 11(2):91-3. PubMed ID: 15755023
[TBL] [Abstract][Full Text] [Related]
8. Relationship between changes in prostate-specific antigen and the percent of prostatic epithelium in men with benign prostatic hyperplasia.
Cadeddu JA; Pearson JD; Lee BR; Landis P; Partin AW; Epstein JI; Carter HB
Urology; 1995 May; 45(5):795-800. PubMed ID: 7538241
[TBL] [Abstract][Full Text] [Related]
9. Morphometric analysis of pediatric and nonhyperplastic prostate glands: evidence that BPH is not a unique stromal process.
Shapiro E; Hartanto V; Perlman EJ; Tang R; Wang B; Lepor H
Prostate; 1997 Nov; 33(3):177-82. PubMed ID: 9365545
[TBL] [Abstract][Full Text] [Related]
10. Should the diagnosis of benign prostatic hyperplasia be made on prostate needle biopsy?
Viglione MP; Potter S; Partin AW; Lesniak MS; Epstein JI
Hum Pathol; 2002 Aug; 33(8):796-800. PubMed ID: 12203211
[TBL] [Abstract][Full Text] [Related]
11. Morphometry of benign prostatic hyperplasia during androgen suppressive therapy. Relationships among epithelial content, PSA density, and clinical outcome.
Svindland A; Eri LM; Tveter KJ
Scand J Urol Nephrol Suppl; 1996; 179():113-7. PubMed ID: 8908676
[TBL] [Abstract][Full Text] [Related]
12. Correlation of biochemical (receptors, endogenous tissue hormones) and quantitative morphologic (stereologic) findings in normal and hyperplastic human prostates.
Bartsch G; Keen F; Daxenbichler G; Marth C; Margreiter R; Brüngger A; Sutter T; Rohr HP
J Urol; 1987 Mar; 137(3):559-64. PubMed ID: 2434669
[TBL] [Abstract][Full Text] [Related]
13. Prostatic epithelial and luminal area in the transition zone acini: morphometric analysis in normal and hyperplastic human prostate.
Babinski MA; Chagas MA; Costa WS; Sampaio FJ
BJU Int; 2003 Oct; 92(6):592-6. PubMed ID: 14511041
[TBL] [Abstract][Full Text] [Related]
14. Total and Gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in serum from patients with prostate cancer or benign prostatic biopsies.
Haese A; Graefen M; Steuber T; Becker C; Noldus J; Erbersdobler A; Huland E; Huland H; Lilja H
J Urol; 2003 Dec; 170(6 Pt 1):2269-73. PubMed ID: 14634394
[TBL] [Abstract][Full Text] [Related]
15. Prostate tissue composition and response to finasteride in men with symptomatic benign prostatic hyperplasia.
Marks LS; Partin AW; Gormley GJ; Dorey FJ; Shery ED; Garris JB; Subong EN; Stoner E; deKernion JB
J Urol; 1997 Jun; 157(6):2171-8. PubMed ID: 9146609
[TBL] [Abstract][Full Text] [Related]
16. Stromal nodules in benign prostatic hyperplasia.
Bierhoff E; Vogel J; Benz M; Giefer T; Wernert N; Pfeifer U
Eur Urol; 1996; 29(3):345-54. PubMed ID: 8740022
[TBL] [Abstract][Full Text] [Related]
17. Prostatic volume and ratio of free-to-total prostate specific antigen in patients with prostatic cancer or benign prostatic hyperplasia.
Haese A; Graefen M; Noldus J; Hammerer P; Huland E; Huland H
J Urol; 1997 Dec; 158(6):2188-92. PubMed ID: 9366341
[TBL] [Abstract][Full Text] [Related]
18. Bipolar plasma enucleation of the prostate vs open prostatectomy in large benign prostatic hyperplasia cases - a medium term, prospective, randomized comparison.
Geavlete B; Stanescu F; Iacoboaie C; Geavlete P
BJU Int; 2013 May; 111(5):793-803. PubMed ID: 23469933
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the mechanism of discrepant nuclear morphometric results comparing preoperative biopsy and prostatectomy specimens.
Kanamaru H; Zhang YH; Takahashi M; Nakamura N; Ishida H; Akino H; Muranaka K; Okada K
Urology; 2000 Aug; 56(2):342-5. PubMed ID: 10925120
[TBL] [Abstract][Full Text] [Related]
20. Possible clinical implications of prostate capsule thickness and glandular epithelial cell density in benign prostate hyperplasia.
Holder KG; Galvan B; Knight AS; Ha F; Collins R; Weaver PE; Brandi L; de Riese WT
Investig Clin Urol; 2021 Jul; 62(4):423-429. PubMed ID: 34085792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
